Dr. Bass’ recent article in Contemporary Pediatrics, “Personalized medicine, right drug, right patient, right time,” provides a miniature but profound view of what may be the future of pediatric healthcare: focusing on healthcare that is truly individualized through precision science in the areas of diagnosis and treatment, rather than generalized, population-based treatment guidelines.
The premise is to use a patient’s own genetic information to guide decisions for prevention, diagnosis, and treatment of disease and other health conditions.
Diagnosis of attention-deficit/hyperactivity disorder (ADHD) at age 9 years is associated with adverse childhood experiences (ACEs), according to an analysis of data for 1572 children who are part of the Fragile Families and Child Wellbeing Study (FFCWS) birth cohort.
A longitudinal study examined the relationship between prenatal or postnatal high-fat, high-sugar diet and symptoms of attention-deficit/hyperactivity disorder (ADHD) in children who demonstrated either early-onset persistent conduct disorder or minimal conduct problems.
Children with ADHD are more likely than their peers to consume less water, exercise less, and spend more time staring at screens—all behaviors that may be negatively affecting their ADHD symptoms, according to a new report.